Bacterin Announces Distribution Agreement With Spartan

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Bacterin Announces Distribution Agreement With Spartan Medical for DOD and VA Medical Centers

BELGRADE, Mont., March 10, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material, today announced it has signed a national distribution agreement with Spartan Medical, Inc., a service-disabled, veteran-owned, small business focused on distribution to government medical facilities.

Under the agreement, Spartan Medical will distribute Bacterin's proprietary product portfolio to the medical centers affiliated with the US Department of Defense (DOD) and the US Department of Veteran's Affairs (VA). Spartan Medical is an established distribution entity that provides best-in-class products and services to its customers, with specific experience in orthopedic and biologics distribution, and government contracting.

"Spartan Medical is constantly on the lookout for the best products in the world that will improve surgical outcomes for those who have served," said Vince Proffitt, President of Spartan Medical, Inc. "Our relationship with Bacterin does just that and makes our Biologics offering second to none."

Melanie Head, Bacterin's Vice President of Sales added, "Our new relationship with Spartan Medical is both a great privilege and wonderful opportunity. It will enable us to provide our military personnel, soldiers and veterans with the biologics they deserve to enhance the quality of their lives, while also adding another experienced distribution channel to our organization."

About Spartan Medical

Spartan Medical Inc. was founded in 2008 by a former Air Force Intelligence Officer in an effort to provide an extensive armamentarium of advanced medical devices and technologies focused on the needs of the VA and DoD Surgeon. Spartan Medical is considered a top priority vendor in the VA as a verified Service-Disabled Veteran-Owned Small Business (SDVOSB), and has secured multi-year Blanket Purchase Agreements at 30 major Military Treatment Facilities. With a core staff possessing over 200 years of combined expertise and experience in the field, and numerous highly trained and skilled sales consultants across the nation, Spartan Medical assures no single points of failure. Consistent with its mission to provide the best products and services to our nation's Wounded Warriors and Veterans, Spartan Medical has recently collaborated with Bacterin International to provide innovative, state-of-the-art, clinically proven medical implants that meet the ongoing challenges involved in patient surgical care.

For further information please visit: www.spartanmedspine.com

About   Bacterin International Holdings

Bacterin International Holdings, Inc. (NYSE MKT:BONE) develops, manufactures and markets biologic products to domestic and international markets. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.

For further information, please visit  www.bacterin.com .

Important Cautions Regarding Forward-looking Statements

This news release contains certain disclosures that may be deemed forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to significant risks and uncertainties. Forward-looking statements include statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as "continue," "efforts," "expects," "anticipates," "intends," "plans," "believes," "estimates," "projects," "forecasts," "strategy," "will," "goal," "target," "prospects," "potential," "optimistic," "confident," "likely," "probable" or similar expressions or the negative thereof. Statements of historical fact also may be deemed to be forward-looking statements. We caution that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others: the Company's ability to meet its existing and anticipated contractual obligations, including financial covenant and other obligations contained in the Company's secured lending facility; the Company's ability to manage cash flow and achieve profitability; the Company's ability to remain listed on the NYSE MKT; the Company's ability to develop, market, sell and distribute desirable applications, products and services and to protect its intellectual property; the ability of the Company's sales force to achieve expected results; the ability of the Company's customers to pay and the timeliness of such payments; the Company's ability to obtain financing as and when needed; changes in consumer demands and preferences; the Company's ability to attract and retain management and employees with appropriate skills and expertise; the Company's ability to successfully conclude government investigations; the impact of changes in market, legal and regulatory conditions and in the applicable business environment, including actions of competitors; and other factors. Additional risk factors are listed in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q under the heading "Risk Factors." The Company undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

Investor Contact: COCKRELL GROUP Rich Cockrell 877-889-1972 cockrellgroup.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 292

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 85

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 77

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading
Life Insurance: Evolving with Your Financial Journey

Updated Category News Views 56

Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...

Continue Reading
Go NYC's Perks: Making Commutes Rewarding in NYC

Updated Category News Views 136

Go NYC's Perks: Turning Commutes into Gains I’ve seen a lot of schemes aimed at getting folks to change their travel habits, but this one from Go NYC caught my attention. These guys are trying to squeeze some extra value out of the daily grind for anyone hoofing it across the Big Apple. A new rewards program named Perks kicks off, offering all kinds of discounts and...

Continue Reading
Better Life Science: Revolutionizing At-Home STI Testing

Updated Category News Views 171

Paving a New Path for STI Testing Accessibility The landscape of STI testing is undergoing a significant shift, and Better Life Science is at the helm with their innovative STD Hero at-home testing service. With a splash in the latest AVN report, they're turning heads in both the clinical world and in mainstream society. This ain't just about checking boxes in health...

Continue Reading
PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 96

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 156

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading
SGRY Acquisition Under Scrutiny: Fairness Questioned

Updated Category News Views 203

Questions Hover Over SGRY Acquisition Here's a real jaw-dropper for you. Surgery Partners, Inc. (NASDAQ: SGRY) is getting clocks cleaned in a fairness probe over its acquisition terms. If you thought this ride was smooth, think again—Levi & Korsinsky, LLP has put the brakes on any such assumptions, launching an investigation that’s sure to raise some eyebrows. What's...

Continue Reading
NVIDIA Faces Turbulent Storm with CEO Resignation

Updated Category News Views 139

Huang's Unexpected Exit and NVIDIA's Rocky Road Well, talk about drama in Silicon Valley. When executives start stumbling, it's not just some PR nightmare—it's a full-on crisis. NVIDIA's co-founder and CEO Jensen Huang is calling it quits, and not on some smooth, idyllic note. No, this is the kind of exit that investors dread. You’ve got affairs, security concerns,...

Continue Reading

Top 5 Most Recently Viewed Articles

Nord Anglia's Private Schools Shine in 2026 National Rankings

Updated Category News Views 363

Nord Anglia's Schools Excel in National Rankings Nord Anglia schools ranked in the top 0.5 to 2% nationally Nord Anglia Education is proud to announce that its schools across the United States have achieved remarkable positions among the leading private schools nationwide, according to the latest Niche rankings for 2026. Unveiling Exceptional Educational Achievements This...

Continue Reading
Ingevity's Leadership Change: New Interim CEO Appointed

Updated Category News Views 151

Ingevity Announces CEO Transition Ingevity Corporation (NYSE: NGVT) has experienced a significant change in its leadership with John Fortson stepping down as president and chief executive officer. Following his departure, the company has entrusted board director Luis Fernandez-Moreno with the role of interim president and CEO while a search is underway for a permanent...

Continue Reading
Projected Growth of Supply Chain Security Market by 2030

Updated Category News Views 165

Growth Prospects of the Supply Chain Security Market The global Supply Chain Security Market is set for significant growth, projected to reach USD 5.14 billion by 2030, up from USD 2.52 billion in 2024. The expected compound annual growth rate (CAGR) during this period is 12.6%, indicating robust expansion in a field that safeguards vital supply chain operations. Scope...

Continue Reading
KLA Corporation's Impressive Fiscal 2026 Q2 Performance Review

Updated Category News Views 249

KLA Corporation's Fiscal 2026 Quarter Two Results Overview KLA Corporation (NASDAQ: KLAC) has reported robust financial results for the second quarter of fiscal year 2026, significantly surpassing expectations. These results underline the company’s powerful position within the semiconductor manufacturing industry. Financial Highlights Revenue Performance The company's...

Continue Reading
Heidi Hunter Steps Up as Vice Chair at Bavarian Nordic Board

Updated Category News Views 152

Heidi Hunter's New Role at Bavarian Nordic Recently, Bavarian Nordic A/S (Copenhagen: BAVA) announced an exciting development by appointing Heidi Hunter as the new Vice Chair of its Board of Directors. This decision follows the recent elevation of Anne Louise Eberhard to Chair, marking a shift in leadership aimed at steering the company forward in the pharmaceutical...

Continue Reading